NPM: Bone Grafting Material, Animal Source

Product code NPM, “Bone Grafting Material, Animal Source” in FDA's classification database, is a Class II device type under 21 CFR 872.3930 (bone grafting material), reviewed by FDA's Dental panel. FDA's 510(k) database lists 42 clearances under NPM, 37 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
NPM
Regulation
21 CFR 872.3930
Class
II
Panel
Dental
Clearances
42
Most recent
Oct 9, 2026
Median review, last 2 years
200 days
Third-party review
Not eligible
Implant
Yes

What it covers

A animal-source bone grafting material is a naturally-derived device, such as collagen, intended to fill, augment, or reconstruct periodontal defects and or bony defects of the upper or lower jaw.

FDA’s definition of product code NPM, from the Product Classification database.

FDA flags NPM devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K260096Wishbone HAEWishbone SAOct 9, 2026Traditional
K254210REBOHIL (BGM-1, BGM-2, BGM-3, BGM-4, BGM-5)Hyundai Bioland Co., Ltd.Sep 25, 2026Traditional
K253723BOSSMedpark Co., Ltd.Jun 16, 2026Traditional
K251786Geistlich Bio-Oss®; Geistlich Bio-Oss Pen®Geistlich Pharma AGJul 11, 2025Special
K251613SwissGraft XGeistlich Pharma AGJun 26, 2025Special
K242510Geistlich Bio-Flow®Geistlich Pharma AGMar 7, 2025Traditional
K240133Xenograft Bovine Bone ParticulateCollagen Solutions, LLCAug 16, 2024Traditional
K230305THE Graft CollagenPurgo Biologics, Inc.Jul 24, 2024Traditional
K240661Geistlich Bio-Oss®Geistlich Pharma AGJul 12, 2024Traditional
K231672S1Medpark Co., Ltd.Oct 13, 2023Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 42 with a free account)

Clearances by year

37 NPM 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)3269
2025330
20243211
20232198
20212167
20203231
20182312
20175191
20161422
20154349
20142319
20132295
20122147
20113112

Who submits

19 applicants cleared a NPM device since 2011. 59% of the clearances went to applicants in United States, then South Korea (19%), Switzerland (14%) and Belgium (5%). By type: Traditional 84%, Abbreviated 11% and Special 5%.

ApplicantClearances since 2011
Geistlich Pharma AG8
Collagen Matrix, Inc.6
Purgo Biologics, Inc.3
Medpark Co., Ltd.2
Nibec Co., Ltd.2
Sigmagraft, Inc.2
Wishbone SA2
Chiyewon1

How FDA classifies it

(1) Class II (special controls) for bone grafting materials that do not contain a drug that is a therapeutic biologic. The special control is FDA's “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” (See § 872.1(e) for the availability of this guidance document.)

(2) Class III (premarket approval) for bone grafting materials that contain a drug that is a therapeutic biologic. Bone grafting materials that contain a drug that is a therapeutic biologic, such as biological response modifiers, require premarket approval.

From 21 CFR 872.3930. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 872.3930 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NPM clearances declared.

Ask about NPM

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about NPM

What is FDA product code NPM?

Product code NPM, “Bone Grafting Material, Animal Source” in FDA's classification database, is a Class II device type under 21 CFR 872.3930 (bone grafting material), reviewed by FDA's Dental panel. FDA's 510(k) database lists 42 clearances under NPM, 37 of them since 2011.

How many 510(k) clearances are there under NPM?

FDA’s 510(k) database listed 42 clearances under NPM as of Oct 29, 2026, 37 of them decided since 2011; the most recent decision was Oct 9, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a NPM 510(k)?

For the 6 NPM clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 200 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most NPM clearances?

Since 2011: Geistlich Pharma AG (8), Collagen Matrix, Inc. (6), Purgo Biologics, Inc. (3), Medpark Co., Ltd. (2) and Nibec Co., Ltd. (2). 19 applicants have cleared a NPM device in that time.

Sources

  1. FDA product classification: NPM · Product Classification database
  2. 21 CFR 872.3930: Bone grafting material · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for NPM · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow NPMGet an email when FDA clears, recalls or publishes guidance for NPM devices.

Know what FDA already cleared.